+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Cannabis Market - Global Forecast 2025-2032

  • PDF Icon

    Report

  • 183 Pages
  • October 2025
  • Region: Global
  • 360iResearch™
  • ID: 5012913
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The global cannabis market is experiencing fundamental change as advances in regulation, product innovation, and consumer adoption accelerate industry transformation. Senior decision-makers face a complex competitive environment where informed strategies and robust analytics are vital for sustained growth.

Market Snapshot: Cannabis Market Size, CAGR, and Growth Outlook

The Cannabis Market expanded from USD 30.96 billion in 2024 to USD 34.92 billion in 2025 and is projected to reach USD 83.71 billion by 2032, advancing at a CAGR of 13.23%. This growth reflects clear momentum from worldwide regulatory reform, increasing investment across cultivation and supply chain technology, and the broadening scope of both medical and recreational applications. The evolving regulatory environment not only encourages new business models but also intensifies competition as markets open and mature. Investment in state-of-the-art cultivation supports higher yields and quality, while global consumer preferences drive exploration of new product types and usage occasions.

Cannabis Market Scope & Segmentation by Product, Channel, and Region

This report delivers in-depth segmentation to support benchmarking and strategic planning across the global cannabis value chain. Each segment is analyzed to reveal evolving trends, opportunity mapping, and the relevance of technology and regulation within regional contexts:

  • Product Type: Includes edibles, baked goods, beverages, gummies, flower variants (hybrid, indica, sativa), oil and extracts (concentrates, distillates, shatter, wax), tinctures, topicals such as balms, creams, lotions, and vape products, meeting diverse consumer needs.
  • Source: Segregates production from hemp and marijuana, informing supply chain decisions and compliance measures.
  • Cultivation Method: Encompasses indoor and outdoor growing environments, each presenting unique demands for operational control and scalability.
  • Active Ingredient: Explores balanced, CBD-dominant, and THC-dominant profiles, reflecting the importance of targeted formulations for both medicinal and recreational users.
  • Application: Categorizes usage in medical and recreational settings, each with distinct regulatory and commercial dynamics.
  • End User: Focuses on food and beverage companies, pharmaceutical firms, research institutions, and wellness and personal care enterprises, highlighting the value chain’s reach beyond traditional channels.
  • Distribution Channel: Analyzes offline and online routes to market, enabling flexibility and wider consumer engagement.
  • Regions: Covers Americas (including United States, Canada, Mexico, Brazil, Argentina, Chile, Colombia, Peru), Europe, Middle East and Africa (such as United Kingdom, Germany, France, Russia, and several others), and Asia-Pacific (including China, India, Japan, Australia, South Korea, Indonesia, Thailand, Malaysia, Singapore, Taiwan) to provide a balanced global perspective.
  • Key Companies: Profiles market leaders and innovators such as Acreage Holdings, Tilray, Inc., Aurora Cannabis Inc., Cannabis Science Inc., Chronos Group Inc., Cresco Labs, Inc., Curaleaf Holdings, Inc., CV Sciences Inc., EcoGen Biosciences by Kadenwood, Elixinol Wellness Limited, Extractas Bioscience, Folium Europe B.V., Green Thumb Industries Inc., Lexaria Bioscience Corp., Medical Marijuana, Inc., MediPharm Labs Inc., Organigram Holdings Inc., Peace Naturals Project Inc., StenoCare A/S, The Seed Cellar, and Tikun Olam.

Key Takeaways: Strategic Insights for Senior Stakeholders

  • Regulatory evolution is opening new channels and fostering cross-industry partnerships, establishing industry standards and expanding global access.
  • Increasing consumer awareness drives demand for innovative formats such as edibles, tinctures, and topicals, putting pressure on companies to broaden portfolios and refine product strategies.
  • Advanced cultivation technology and transparent supply chains are growing in importance, as consistent quality and strict compliance become pivotal for competitive differentiation in regulated markets.
  • Corporate commitments to sustainability and social equity are shaping brand strategies, drawing stakeholders who prioritize responsible business and shared values.
  • Adoption of robust analytics and enhancements in direct-to-consumer technology enable tailored offerings and foster brand loyalty across multiple geographies.

Tariff Impact: Navigating New Trade Pressures

Recent US tariffs are prompting industry participants to reconfigure trade strategies, emphasizing onshore investments in cultivation and processing. Exporters and importers are reevaluating sourcing channels and distribution partners, increasing resilience by diversifying supplier networks and integrating climate-controlled production. Achieving quality assurance and full compliance through vertically integrated operations remains pivotal for adapting to evolving tariff requirements.

Methodology & Data Sources: Rigorous Cannabis Market Intelligence

This report’s insights are derived from direct interviews with senior market participants alongside analysis of regulatory filings, industry publications, and peer-reviewed studies. Triangulated findings and third-party validation underpin the reliability and relevance of all strategic recommendations.

Why This Report Matters for the Cannabis Market

  • Provides clear guidance for regulatory compliance, operational efficiency, and investment prioritization in the cannabis sector.
  • Enables competitive benchmarking and strategic opportunity identification across a spectrum of segments, technologies, and geographic markets.
  • Equips leaders with actionable market intelligence to drive informed, agile growth decisions.

Conclusion

Senior executives and industry leaders can leverage this report as a robust tool to navigate ongoing industry change, capitalize on sector opportunities, and address regulatory and consumer shifts guiding the future of cannabis markets.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Emergence of cannabis beverage market with functional infused sodas and spiked sparkling water
5.2. Rising consumer demand for broad spectrum cbd wellness products drives premium pricing strategies
5.3. Expansion of adult use cannabis tourism with destination dispensaries and immersive consumer experiences
5.4. Impact of federal banking reform on cannabis operators’ access to capital and growth funding
5.5. Rapid growth of low-dose microdosing cannabis edibles targeting health conscious consumers
5.6. Integration of blockchain technology for secure cannabis supply chain transparency and compliance
5.7. Proliferation of cannabis infused pet products prompting regulatory scrutiny and safety testing gaps
6. Cumulative Impact of United States Tariffs 2025
7. Cumulative Impact of Artificial Intelligence 2025
8. Cannabis Market, by Product Type
8.1. Edibles
8.1.1. Baked Goods
8.1.2. Beverages
8.1.3. Gummies
8.2. Flower
8.2.1. Hybrid
8.2.2. Indica
8.2.3. Sativa
8.3. Oil & Extract
8.3.1. Concentrates
8.3.2. Distillates
8.3.3. Shatter
8.3.4. Wax
8.4. Tinctures
8.5. Topicals
8.5.1. Balms
8.5.2. Creams
8.5.3. Lotions
8.6. Vape
9. Cannabis Market, by Source
9.1. Hemp
9.2. Marijuana
10. Cannabis Market, by Cultivation Method
10.1. Indoor
10.2. Outdoor
11. Cannabis Market, by Active Ingredient
11.1. Balanced
11.2. CBD Dominant
11.3. THC Dominant
12. Cannabis Market, by Application
12.1. Medical
12.2. Recreational
13. Cannabis Market, by End User
13.1. Food & Beverage Companies
13.2. Pharmaceutical Companies
13.3. Research Institutions
13.4. Wellness & Personal Care
14. Cannabis Market, by Distribution Channel
14.1. Offline
14.2. Online
15. Cannabis Market, by Region
15.1. Americas
15.1.1. North America
15.1.2. Latin America
15.2. Europe, Middle East & Africa
15.2.1. Europe
15.2.2. Middle East
15.2.3. Africa
15.3. Asia-Pacific
16. Cannabis Market, by Group
16.1. ASEAN
16.2. GCC
16.3. European Union
16.4. BRICS
16.5. G7
16.6. NATO
17. Cannabis Market, by Country
17.1. United States
17.2. Canada
17.3. Mexico
17.4. Brazil
17.5. United Kingdom
17.6. Germany
17.7. France
17.8. Russia
17.9. Italy
17.10. Spain
17.11. China
17.12. India
17.13. Japan
17.14. Australia
17.15. South Korea
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Acreage Holdings
18.3.2. Tilray, Inc.
18.3.3. Aurora Cannabis Inc.
18.3.4. Cannabis Science Inc.
18.3.5. Chronos Group Inc.
18.3.6. Cresco Labs, Inc.
18.3.7. Curaleaf Holdings, Inc.
18.3.8. CV Sciences Inc.
18.3.9. EcoGen Biosciences by Kadenwood
18.3.10. Elixinol Wellness Limited
18.3.11. Extractas Bioscience
18.3.12. Folium Europe B.V.
18.3.13. Green Thumb Industries Inc.
18.3.14. Lexaria Bioscience Corp.
18.3.15. Medical Marijuana, Inc.
18.3.16. MediPharm Labs Inc.
18.3.17. Organigram Holdings Inc.
18.3.18. Peace Naturals Project Inc.
18.3.19. StenoCare A/S
18.3.20. The Seed Cellar
18.3.21. Tikun Olam
List of Tables
List of Figures

Samples

Loading
LOADING...

Companies Mentioned

The key companies profiled in this Cannabis market report include:
  • Acreage Holdings
  • Tilray, Inc.
  • Aurora Cannabis Inc.
  • Cannabis Science Inc.
  • Chronos Group Inc.
  • Cresco Labs, Inc.
  • Curaleaf Holdings, Inc.
  • CV Sciences Inc.
  • EcoGen Biosciences by Kadenwood
  • Elixinol Wellness Limited
  • Extractas Bioscience
  • Folium Europe B.V.
  • Green Thumb Industries Inc.
  • Lexaria Bioscience Corp.
  • Medical Marijuana, Inc.
  • MediPharm Labs Inc.
  • Organigram Holdings Inc.
  • Peace Naturals Project Inc.
  • StenoCare A/S
  • The Seed Cellar
  • Tikun Olam

Table Information